BRIEF-China Resources Sanjiu Gets State Asset Regulator's Approval To Buy Stake In Tasly

Reuters2025-02-06

Feb 6 (Reuters) - Tasly Pharmaceutical Group Co Ltd 600535.SS:

SAYS CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO LTD 000999.SZ GETS STATE ASSET REGULATOR'S APPROVAL FOR BUYING STAKE IN COMPANY

Source text

Further company coverage: 600535.SS

(Reporting by Beijing Newsroom)

((yukun.zhang@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2509244486?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-06 17:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509244486","market":"us","top_or_hot":-1,"title":"BRIEF-China Resources Sanjiu Gets State Asset Regulator's Approval To Buy Stake In Tasly","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-China Resources Sanjiu Gets State Asset Regulator's Approval To Buy Stake In Tasly</title></head><body><p><span>Feb 6 (Reuters)</span><span> - </span>Tasly Pharmaceutical Group Co Ltd <span>600535.SS</span>:</p><ul><li><p>SAYS CHINA RESOURCES SANJIU MEDICAL &amp; PHARMACEUTICAL CO LTD  <span>000999.SZ</span> GETS STATE ASSET REGULATOR'S APPROVAL FOR BUYING STAKE IN COMPANY</p></li></ul><p>Source text</p><p>Further company coverage: <span>600535.SS</span></p><p> (Reporting by Beijing Newsroom)</p><p> ((yukun.zhang@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-China Resources Sanjiu Gets State Asset Regulator's Approval To Buy Stake In Tasly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-China Resources Sanjiu Gets State Asset Regulator's Approval To Buy Stake In Tasly\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-06 17:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-China Resources Sanjiu Gets State Asset Regulator's Approval To Buy Stake In Tasly</title></head><body><p><span>Feb 6 (Reuters)</span><span> - </span>Tasly Pharmaceutical Group Co Ltd <span>600535.SS</span>:</p><ul><li><p>SAYS CHINA RESOURCES SANJIU MEDICAL &amp; PHARMACEUTICAL CO LTD  <span>000999.SZ</span> GETS STATE ASSET REGULATOR'S APPROVAL FOR BUYING STAKE IN COMPANY</p></li></ul><p>Source text</p><p>Further company coverage: <span>600535.SS</span></p><p> (Reporting by Beijing Newsroom)</p><p> ((yukun.zhang@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0175","symbol_name":"白马股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nL4N3OX0U1:1","article_id":"2509244486","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509244486","pubTimestamp":1738833012,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-China Resources Sanjiu Gets State Asset Regulator's Approval To Buy Stake In TaslyFeb 6  - Tasly Pharmaceutical Group Co Ltd 600535.SS:SAYS CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO LTD  000999.SZ GETS STATE ASSET REGULATOR'S APPROVAL FOR BUYING STAKE IN COMPANYSource textFurther company coverage: 600535.SS  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600535":"天士力","BK0175":"白马股","BK0012":"证金概念","BK0196":"行业龙头","BK0060":"抗癌","BK0010":"央企","BK0028":"国家队","BK0239":"医药制造","BK0185":"二线龙头","BK0183":"MSCI概念","000999":"华润三九","BK0188":"融资融券"},"translate_title":"简报-华润三九入股天士力获国资监管机构批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600535":0.9,"000999":0.9},"content_text":"BRIEF-China Resources Sanjiu Gets State Asset Regulator's Approval To Buy Stake In TaslyFeb 6 (Reuters) - Tasly Pharmaceutical Group Co Ltd 600535.SS:SAYS CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO LTD  000999.SZ GETS STATE ASSET REGULATOR'S APPROVAL FOR BUYING STAKE IN COMPANYSource textFurther company coverage: 600535.SS (Reporting by Beijing Newsroom) ((yukun.zhang@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2509244486","isCrawlerRequest":true}